Screener
Travere Therapeutics, Inc. TVTX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Assets | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Marketable debt securities, at fair value | 186,314 | 229,761 |
| Accounts receivable, net | 87,302 | 80,134 |
| Inventory | 6,356 | 5,875 |
| Prepaid expenses and other current assets | 34,347 | 28,760 |
| Total current assets | 392,681 | 437,565 |
| Long-term inventory | 30,698 | 30,280 |
| Property and equipment, net | 3,627 | 4,022 |
| Operating lease right of use assets | 9,668 | 10,576 |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s prepaid & other current?
- Travere Therapeutics, Inc. (TVTX) reported prepaid & other current of $34.35M in Q1 2026.
- How has Travere Therapeutics, Inc.'s prepaid & other current changed year-over-year?
- Travere Therapeutics, Inc.'s prepaid & other current increased by 152.3% year-over-year, from $13.62M to $34.35M.
- What is the long-term trend for Travere Therapeutics, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s prepaid & other current has grown at a 28.7% compound annual growth rate (CAGR), from $8.14M to $28.76M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Travere Therapeutics, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude